The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.

Nvidia (NVDA) shares recently found strong buying support at below $175. That led to an uptrend, followed by a 3.01% lift for ...

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...

From nuclear fusion and biosecurity to delivery robots and online college, here’s a detailed look at Sam Altman’s startup ...

Wall Street wavered on Friday, amid small moves and low trading volume post the Christmas holiday. Precious metals grabbed the spotlight as they extended their meteoric rise this year. The tech-heavy ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Craif Inc. in Nagoya, Japan, working with Nagoya University's Institute of Innovation for Future Society, has developed a ...

In 2023, the AI market in pharmaceuticals and biotech was valued at $1.8 billion, and it’s expected to grow to $13.1 billion ...

Samsung Biologics acquires Human Genome Sciences from GSK for $280 million, expanding its US manufacturing footprint. The ...

Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.

This stock is a great choice for cautious and aggressive investors.